Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A malignant glandular epithelial neoplasm arising from the ovary. It is characterized by the presence of clear and hobnail cells and cystic structures.
Biomarker and diagnostic research for ovarian clear cell cystadenocarcinoma has been reported in the published literature.
3 clinical trials registered. Interventions under study include drug therapy, other interventions, and biologic therapy. Pipeline includes 2 PHASE2, 1 PHASE1. Research is primarily sponsored by academic and government institutions.
25 publications have been identified in PubMed for ovarian clear cell cystadenocarcinoma. Research spans Diagnostic / Biomarker (24%), Epidemiology / Natural History (20%), and Clinical Trial Publication (12%).
Research Type | Count | % of Total |
|---|---|---|
Testing and diagnosis research | 6 |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 6:52 AM UTC
24%
Disease patterns and progression | 5 | 20% |
Clinical study results | 3 | 12% |
Laboratory research | 3 | 12% |
New treatment approaches | 3 | 12% |
Research summaries | 2 | 8% |
Patient case studies | 2 | 8% |
Other research | 1 | 4% |
Li CL (2026). [PMID: 41957787](https://pubmed.ncbi.nlm.nih.gov/41957787/). *J Ovarian Res*. [Review / Meta-Analysis]
Iwabuchi E (2026). [PMID: 41693303](https://pubmed.ncbi.nlm.nih.gov/41693303/). *Pathology international*. [Diagnostic / Biomarker]
Chui MH (2026). [PMID: 41397226](https://pubmed.ncbi.nlm.nih.gov/41397226/). *Int J Gynecol Pathol*. [Other]
Liu P (2026). [PMID: 41455287](https://pubmed.ncbi.nlm.nih.gov/41455287/). *European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology*. [Diagnostic / Biomarker]
Leung YY (2025). [PMID: 40150910](https://pubmed.ncbi.nlm.nih.gov/40150910/). *Journal of gynecologic oncology*. [Epidemiology / Natural History]
Nakamura K (2025). [PMID: 39799740](https://pubmed.ncbi.nlm.nih.gov/39799740/). *European journal of obstetrics, gynecology, and reproductive biology*. [Diagnostic / Biomarker]
Lee YJ (2025). [PMID: 40613115](https://pubmed.ncbi.nlm.nih.gov/40613115/). *Journal of gynecologic oncology*. [Gene Therapy / Novel Therapeutics]
Saida T (2025). [PMID: 40591119](https://pubmed.ncbi.nlm.nih.gov/40591119/). *Japanese journal of radiology*. [Diagnostic / Biomarker]
Takahashi M (2025). [PMID: 39840716](https://pubmed.ncbi.nlm.nih.gov/39840716/). *Cancer medicine*. [Basic Science / Preclinical]
Kordowitzki P (2025). [PMID: 40252048](https://pubmed.ncbi.nlm.nih.gov/40252048/). *CA: a cancer journal for clinicians*. [Review / Meta-Analysis]